Kodiak Sciences (KOD)

• Market cap: $1.2B
• 1 day: -1.39%
• 5 days: -9.74%
• 1 month: 14.47%
• 3 months: 143.3%
• 6 months: 506.95%
• Year to date: 163.34%
• 1 year: 179.56%
• 5 years: -83.18%
• 10 years: 123.43%
• Sector: Healthcare
• Industry: Biotechnology

About: Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Employees: 121